Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
Current Signal: SELL (auto-tracking)
2.47% $4.15
America/New_York / 23 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 87.77 mill |
EPS: | -0.370 |
P/E: | -11.22 |
Earnings Date: | May 20, 2024 |
SharesOutstanding: | 21.15 mill |
Avg Daily Volume: | 0.396 mill |
RATING 2024-04-23 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -11.22 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-1.54x |
Company: PE -11.22 | industry: PE 7.30 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 3.95 - 4.35 ( +/- 4.84%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | Moseley Mark Bradley Jr | Buy | 14 000 | Common Stock |
2023-11-09 | Fulgoni Gian | Buy | 41 000 | Common Stock |
2023-11-03 | Hulett Mathew N | Buy | 13 850 | Common Stock |
2023-11-03 | Chambers Christine | Buy | 6 888 | Common Stock |
2023-08-14 | Smith Jacqueline Paula | Buy | 6 000 | Common Stock -Restricted Stock Units |
INSIDER POWER |
---|
97.05 |
Last 100 transactions |
Buy: 504 288 | Sell: 401 224 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $4.15 (2.47% ) |
Volume | 0.267 mill |
Avg. Vol. | 0.396 mill |
% of Avg. Vol | 67.42 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:34 | sell | $5.86 | N/A | Active |
---|
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.